Riverwater Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Sell
1,984
-70
-3% -$15K 0.12% 149
2026
Q1
$454K Sell
2,054
-12
-0.6% -$2.94K 0.15% 140
2025
Q4
$524K Sell
2,066
-44
-2% -$11.1K 0.2% 119
2025
Q3
$522K Sell
2,110
-80
-4% -$19.1K 0.22% 120
2025
Q2
$526K Sell
2,190
-23
-1% -$5.36K 0.25% 106
2025
Q1
$502K Sell
2,213
-2,588
-54% -$569K 0.26% 99
2024
Q4
$987K Sell
4,801
-46
-0.9% -$10.1K 0.48% 63
2024
Q3
$1.14M Buy
4,847
+864
+22% +$202K 0.56% 51
2024
Q2
$874K Sell
3,983
-63
-2% -$13.7K 0.65% 38
2024
Q1
$910K Buy
4,046
+8
+0.2% +$1.8K 0.67% 36
2023
Q4
$888K Sell
4,038
-97
-2% -$20.5K 0.7% 36
2023
Q3
$907K Sell
4,135
-79
-2% -$17.9K 0.82% 27
2023
Q2
$948K Buy
4,214
+92
+2% +$18.4K 0.84% 27
2023
Q1
$788K Buy
4,122
+291
+8% +$56.2K 0.72% 36
2022
Q4
$708K Buy
3,831
+300
+8% +$52.7K 0.6% 50
2022
Q3
$587K Buy
3,531
+1,230
+53% +$250K 0.59% 55
2022
Q2
$474K Sell
2,301
-950
-29% -$214K 0.48% 64
2022
Q1
$786K Sell
3,251
-183
-5% -$42.4K 1.3% 24
2021
Q4
$836K Buy
+3,434
New +$785K 0.74% 38

Other funds holding STE

Riverwater Partners's STE Position: Q2 2026 in Review

Riverwater Partners reduced its Steris (STE) stake by 3.4% in Q2 2026, selling an estimated $15K and leaving 1,984 shares worth $418K. The position accounts for 0.12% of the portfolio, ranked #149.

Riverwater Partners first reported a position in STE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.14M in Q3 2024. 785 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Riverwater Partners held 1,984 shares of Steris worth $418K as of Q2 2026.
  • Riverwater Partners sold 70 Steris shares in Q2 2026, an estimated $15K.
  • Steris made up 0.12% of Riverwater Partners's portfolio in Q2 2026, its #149 holding.
  • Riverwater Partners first reported a position in Steris in Q4 2021 and has held it in 19 quarters since.
  • Riverwater Partners's Steris position peaked at $1.14M in Q3 2024.
  • 785 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.